| Patents for A61K 45 - Medicinal preparations containing active ingredients not provided for in groups (115,020) |
|---|
| 03/16/1994 | EP0587378A1 Prevention of bone resorption |
| 03/16/1994 | EP0586523A1 Determination of prodrugs metabolizable by the liver and therapeutic use thereof |
| 03/16/1994 | EP0413731B1 Chimeric peptides for neuropeptide delivery through the blood-brain barrier |
| 03/15/1994 | US5294627 Anticholesterol |
| 03/15/1994 | US5294433 Dentistry |
| 03/15/1994 | CA1327750C Therapeutic use of serotonin-antagonists |
| 03/10/1994 | CA2105599A1 Prevention of bone resorption |
| 03/09/1994 | EP0586303A1 Cosmetic or pharmaceutical composition containing an association between a peroxydase and an anti-singlet oxygen agent |
| 03/09/1994 | EP0586020A1 Tetracyclines alone or in combination with NSAID for treating tissue destruction |
| 03/09/1994 | EP0585939A2 TNF ligands |
| 03/09/1994 | EP0585242A1 Wound healing |
| 03/09/1994 | EP0439544B1 In vivo neurotrophic cytoprotective alcohols |
| 03/09/1994 | EP0437487B1 Targetting agents |
| 03/09/1994 | EP0365662B1 Antiglaucoma compositions containing combinations of alpha-2 agonists and beta-blockers |
| 03/09/1994 | EP0262207B1 Beta-lactam antibiotics |
| 03/08/1994 | US5292802 Collagen-polymer tubes for use in vascular surgery |
| 03/08/1994 | US5292513 Method for nonspecific cellular immune stimulation |
| 03/03/1994 | WO1994004702A2 Improved detection and therapy of lesions with biotin/avidin conjugates |
| 03/03/1994 | WO1994004688A2 Cationic peptides and method for production |
| 03/03/1994 | WO1994004674A1 Human melanocyte stimulating hormone receptor |
| 03/03/1994 | WO1994004671A1 Methods and therapeutic compositions for treating cystic fibrosis |
| 03/03/1994 | WO1994004552A1 Opioid receptor genes |
| 03/03/1994 | WO1994004161A1 Use of inhibitors of vacuolar-type h+ atpases |
| 03/03/1994 | WO1994004133A1 Inhalation powder containing antistatic agent |
| 03/03/1994 | WO1994004120A2 Methods of treating sexual dysfunction in animals with and h agonist |
| 03/03/1994 | WO1993023035A3 Use of indolone derivatives for the treatment of memory disorders, sexual dysfunction and parkinson's disease |
| 03/03/1994 | CA2143306A1 Methods and therapeutic compositions for treating cystic fibrosis |
| 03/03/1994 | CA2142881A1 Detection and therapy of lesions with biotin/avidin conjugates |
| 03/03/1994 | CA2142875A1 The use of h2 and h3 agonists to treat sexual dysfunction |
| 03/03/1994 | CA2142313A1 Use of inhibitors of vacuolar-type h atpases |
| 03/03/1994 | CA2142306A1 Cationic peptides and method for production |
| 03/03/1994 | CA2142305A1 Opioid receptor genes |
| 03/02/1994 | EP0584285A1 Improvements in benzodiazepine treatment by cholinesterase inhibitors |
| 03/02/1994 | EP0584273A1 Antibody recognizing endothelial cell ligand for leukocyte cr3 |
| 03/02/1994 | EP0584266A1 Recombinant virus expressing carcinoembryonic antigen and methods of use thereof |
| 03/02/1994 | EP0584264A1 D-type cyclin and uses related thereto |
| 03/02/1994 | EP0584229A1 GLYCAM-1 (Sgp 50), A SELECTIN LIGAND |
| 03/02/1994 | EP0584185A1 Treatment of fatigue syndrome with cholinesterase inhibitors |
| 03/02/1994 | EP0395639B1 Methods and compositions for the treatment of lung conditions |
| 03/02/1994 | EP0266419B1 Fibrinolytic composition |
| 03/01/1994 | US5290784 Aconitane derivatives used as a medication to treat addiction |
| 03/01/1994 | US5290775 Euthanasia compositions |
| 03/01/1994 | US5290572 Calcium salt dispersed in petrolatum |
| 03/01/1994 | US5290561 Patch of room temperature vulcanizable organopolysiloxane rubber, albuterol, diffusion enhancer of normal hydrocarbon alcohol |
| 03/01/1994 | US5290540 Administering, in small particle aerosol form, an anti-inflammatory agent of a corticosteroid, indomethacin, ibuprofen or acetylsalicylic acid and an anti-infectious agent |
| 03/01/1994 | CA1327332C Animal derived cell with antigenic protein introduced therein |
| 03/01/1994 | CA1327316C Certain paf antagonist/antihistamine combinations and methods |
| 03/01/1994 | CA1327315C Cough/cold mixtures comprising non-sedating antihistamine drugs |
| 02/23/1994 | EP0584001A1 Products containing taxol for use in cancer therapy |
| 02/23/1994 | EP0583821A1 Atriopeptins, guanylate cyclase activators, and phosphodiesterase inhibitors as treatment for glaucoma, hydrocephalus and cerebral edema (cranial fluid volume dysfunction) |
| 02/23/1994 | EP0583358A1 Partial liquid breathing of fluorocarbons |
| 02/23/1994 | EP0583356A1 A method for treating infectious respiratory diseases |
| 02/23/1994 | CN1082400A Use of H-2 antagonists for treatment of gingivitis |
| 02/22/1994 | US5288703 Administering syngeristic mixture of animal growth regulator and glutamine |
| 02/17/1994 | WO1994003471A1 Controlled release pharmaceutical formulations of 3'-azido-3'-deoxythymidine and methods of use |
| 02/17/1994 | WO1994003440A1 Benzoxazinones as inhibitors of hiv reverse transcriptase |
| 02/17/1994 | WO1994003202A1 Interleukin-4 stimulated t lymphocyte cell death |
| 02/17/1994 | WO1994003184A1 Compositions for treating and inhibiting gastric and duodenal ulcers |
| 02/17/1994 | WO1994003170A1 Terfenadine metabolites and their optically pure isomers for treating allergic disorders |
| 02/17/1994 | WO1994003162A1 Medicaments for the treatment or prevention of elevated intraocular pressure |
| 02/17/1994 | WO1993020839A3 Use of renin-angiotensin antagonist for reducing post myocardial infarct mobidity and mortality |
| 02/16/1994 | EP0582892A1 Rhenium complexes |
| 02/16/1994 | CN1081909A Methods and compositions for the treatment of diseases with interferon while reducing side effects |
| 02/15/1994 | US5286895 Cholesterol lowering compounds |
| 02/15/1994 | US5286850 Antibody DTPA-type ligand conjugates |
| 02/15/1994 | EP0591458A4 Improved process for the long term reduction of body fat stores, insulin resistance, hyperinsulinemia and hyperglycemia in vertebrates. |
| 02/15/1994 | CA1326994C Proteinase inhibitors for treatment of gastrointestinal ulcer disease |
| 02/09/1994 | EP0582455A1 Benzoxazinones as inhibitors of HIV reverse transcriptase |
| 02/09/1994 | EP0581846A1 Sulfate polysaccharides, preparation method, pharmaceutical composition and utilization |
| 02/09/1994 | EP0581803A1 Compositions and methods of treatment of a variety of disorders utilizing etianate and agonists thereof |
| 02/09/1994 | CN1081614A Synergistic combination of a substance with gastric acid secretion inhibiting effect and an acid degradable antibiotic |
| 02/08/1994 | US5284935 Major histocompatibility complex |
| 02/08/1994 | US5284874 Administering pantetheine |
| 02/08/1994 | US5284843 Pharmacological treatment of ocular development |
| 02/08/1994 | US5284833 Aqueous solution or dry concentrate of a surfactant, an osmotic adjuster and a buffer; nontoxic; biocompatability |
| 02/08/1994 | US5284645 Stable, biocompatible |
| 02/03/1994 | WO1994002633A1 Diagnostic method |
| 02/03/1994 | WO1994002623A1 Blood levels of cck peptides relative to panic disorder treatment |
| 02/03/1994 | WO1994002450A1 Amino acid linked nitrogen mustard derivatives and their use as prodrugs in the treatment of tumours |
| 02/03/1994 | WO1994002108A1 Chemotherapy for cancer |
| 02/03/1994 | WO1994002105A1 Biologically active agent having immunomodulating properties, method for its obtaining and pharmaceutical preparation based on it |
| 02/03/1994 | WO1994002068A1 System of drug delivery to the lymphatic tissues |
| 02/03/1994 | CA2149146A1 Biologically active agent having immuno-modulating properties, method for its obtaining and pharmaceutical preparation based on it |
| 02/03/1994 | CA2149121A1 Biologically active agent having immunomodulating properties, method for its obtaining and pharmaceutical preparation based on it |
| 02/03/1994 | CA2140241A1 Blood levels of cck peptides relative to panic disorder treatment |
| 02/03/1994 | CA2139410A1 Diagnostic method |
| 02/02/1994 | EP0580776A1 Use of sigma receptor antagonists to enhance the effects of antipsychotic drugs |
| 02/01/1994 | USH1286 Administering an anticholesterol agents which is an enzyme inhibitor of angiotensin converting enzyme or/and squalene synthetase |
| 02/01/1994 | CA2075107A1 Pharmaceutical composition of dihydropyridine with neuroleptic |
| 01/26/1994 | EP0579754A1 Use of amines to sensitize multidrug-resistant cells |
| 01/26/1994 | EP0579626A1 Method and agents for promoting wound healing |
| 01/26/1994 | EP0470117B1 Drugs (calcitonin gene-related peptides) for treating erectile dysfunctions |
| 01/26/1994 | EP0428573B1 Method and compositions for the treatment and prevention of septic shock |
| 01/25/1994 | US5281583 LPS-containing analgesics and veterinary analgesics |
| 01/25/1994 | CA1326446C Substance or pharmaceutical or cosmetic composition inhibition or destroying at least one unicellular living creature and/or at least one virus, drug or product containing such a substance, process of manufacture of such substance, chemical compound included in such substance, and process of inhibition or destruction of at least one... |
| 01/20/1994 | WO1994001547A2 A method for generation of antibodies to cell surface molecules |
| 01/20/1994 | WO1994001121A1 Biocidal composition containing mustard seed plant extract |
| 01/20/1994 | WO1994001100A1 METHODS AND COMPOSITIONS FOR INHIBITING 5α-REDUCTASE ACTIVITY |
| 01/20/1994 | WO1994001096A1 Methods and products for treating presbyopia |
| 01/20/1994 | WO1994001095A2 Medicaments for the treatment of visceral pain and migraine |